PATENT CLAIM ANALYSIS

Application Number: 15866787
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "654000"]

Abstract:
Disclosed herein are pharmaceutical compositions for nasal administration comprising tapentadol, their preparation and their use in the treatment of pain.

Claim (Index 1):
A unit dose comprising:\n tapentadol or a pharmaceutically acceptable salt thereof in an amount that is equivalent to about 19.3 mg tapentadol free base and at least one nasal carrier; wherein after intranasal administration to the human, a tapentadol mean Cmax-value achieved by said unit dose ranges from about 40 ng/mL to about 65 ng/mL.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.04762
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15335145', '14882857', '14576357', '14950707', '12047388']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7360423709268474
- 35 USC 102 Novelty (BERT): 0.5267841856330524
- Combined Prediction Score: 0.715116552397468
- Mean Citation Score: 305.51074
- Max Citation Score: 314.98096
- Similarity Product: 208.3832906436348

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test